9IÖÆ×÷³§Ãâ·Ñ

Registration
Location: RI MUHC Atrium - ES1

PART 1:ÌýÌýÌýWHAT’S THE DEAL WITH WOMEN AND HEART DISEASE? WHAT YOU NEED TO KNOW ABOUT SEX AND GENDER DIFFERENCES IN CVD

Eleanor Elstein, MD, Associate Professor, Department of Medicine

Sex-Specific Considerations in Heart Disease

Learning Objectives

1. Recognize biological differences between men and women in the pathophysiology of heart disease
2. Appreciate sex-specific differences in treatment response (and targets) with regard to evidence-based cardiovascular therapy
3. Understand prognostic differences between men and women in CAD and heart failure

Louise Pilote, MDÌýMPhÌýPhD, Professor, Department of Medicine

Moving beyond Sex…Let’s Talk about Gender in Heart Disease

Learning Objectives

1. Define factors contributing to the gender score
2. Appreciate the importance of gender in determining cardiovascular outcomes

Giuseppe Martucci, MD, Assistant Professor, Department of Medicine

Spontaneous Coronary Dissection

Learning Objectives

1. Identify coronary anatomy patterns in men vs. women
2. Review the epidemiology and importance of spontaneous coronary artery dissection in women
3. Appreciate and understand disparity in outcomes after percutaneous coronary revascularization procedures in men and women

Negareh Mousavi, MD, Assistant Professor, Department of Medicine

Link between Cancer and Heart Disease in Women

Learning Objectives

1. Describe the relationship between women with female-specific cancers (reproductive tract, breast) and incident heart disease
2. Review cardiovascular complications of radiotherapy and chemotherapy
3. Recognize the epidemiology rare but important cardiovascular cancers in men and women

PART 2:Ìý TAILORED CARDIOVASCULAR RISK REDUCTION APPROACHES: WHERE ARE WE NOW AND WHERE ARE WE GOING?

Moderator - Natalie Dayan, MD, MSc

Andréane Tardif, RDÌýMSc, HealthÌý Promotion - Project Coordinator, Heart & Stroke (Québec)

Updates on Research in Women's Heart and Brain Health

George Thanassoulis, MDÌýMSc, Associate Professor, Department of Medicine

New Approaches to Prevent Heart Disease in Women

Learning Objectives

1. Review the evidence regarding advanced lipoprotein testing (apoB, Lp(a)) in identifying women at-risk for heart disease
2. Outline how genetics may be integrated into clinical care to identify women at risk for heart disease
3. Illustrate how a benefit-based approach to lipid-lowering may improve the use of lipid-lowering therapy in women

Natalie Dayan, MDÌýMSc, Assistant Professor, Department of Medicine

Pregnancy and Cardiovascular Disease: Getting to the Heart of the Matter

Learning Objectives

1. Review the pregnancy factors that increase a woman’s risk of premature cardiovascular disease
2. Understand the challenges in cardiovascular risk prediction in women
3. Describe the postpartum heart health clinic model such as the 9IÖÆ×÷³§Ãâ·Ñ Maternal Cardiovascular Health clinic

Wendy Wray, RNÌýBScN,ÌýDirector, Women's Healthy Heart Initiative (WHHI), MUHC

Heart Disease Prevention in Women: It’s About Time

Learning Objectives

1. Explain the lack of and barriers to heart diseaseÌýpreventive care accessibility
2. Identify the major components of the current AHA Guidelines of heart disease preventionÌýin women and the importance of lifestyle interventions
3. Make use ofÌýthe structure and process of an example of a Nurse-Led Collaborative clinical model of care for chronic diseases such as heart disease in women

Closing Remarks
Natalie Dayan, MDÌýMSc, Assistant Professor, Department of Medicine